Artiva Biotherapeutics, Inc. Common Stock
Biotechnology
Healthcare
ARTV
24.38 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.69
52 week high
15.83
high
2.86
52 week low
0.00
low
2.58
growth
-79.21 %
previous Close
2.70
P/E ratio
market cap
69.37 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-21.25 M
-4.64 %
eps
0.00 %
-4.82 %
eps surprise
-12.99 %
net profit margin
-2125400000.00 %
0.00 %
operating incoming
-22.81 M
-2.88 %
net change in cash
-1.93 M
79.93 %
cash on hand
28.47 M
-6.36 %
cost of revenue
0.00 %
top top